What Rousselot does

Rousselot is the health-brand and operating subsidiary of Darling Ingredients Inc. (NYSE:DAR), positioned as a global leader in gelatin and collagen peptide ingredients with approximately 30% combined global market share. The company operates 16 production facilities across four continents and offers more than 400 products organized into three core lines: Peptan collagen peptides for health and nutrition applications, functional gelatins for food, pharmaceutical, and nutraceutical uses, and biomaterials (including X-Pure) for biomedical and regenerative medicine research. Sub-brands such as Colartix (joint health) and Nextida GC (metabolic and blood glucose support) extend the portfolio into clinically targeted health claims, protected by multi-jurisdictional patents.

The underlying technology relies on collagen and gelatin ingredient solutions derived from animal agriculture and food industry byproducts under a circular-economy model that is vertically integrated through parent Darling Ingredients. Rousselot's go-to-market is enterprise B2B, with direct sales partnerships to nutraceutical, functional food, pharmaceutical, and biomedical manufacturers, supported by quote-based pricing for custom formulations and volumes. Trade-show presence at Vitafoods, Natural Products Expo West, and COMPAMED, combined with research-driven content marketing, anchors mid-funnel buyer engagement.

Rousselot generates revenue through one-time sales of collagen peptides, gelatins, and biomaterials across four customer segments — Health and Nutrition, Functional Food and Beverage, Pharmaceutical, and Biomedical — with primary emphasis on the first three. Pricing is not publicly disclosed. The company is currently positioning to capture emerging demand from GLP-1 medication users, regenerative medicine developers, and consumers seeking science-backed targeted-health ingredients, while reinforcing sustainability credentials through the Upcycled Certified designation for its Peptan range.

Name

Rousselot

Legal name

Rousselot

Website

https://rousselot.com

Company type

Private

Founded year

1891

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Rousselot is a Darling Ingredients subsidiary and global leader in gelatin and collagen peptide ingredients, holding approximately 30% combined market share across 16 production sites on four continents. It supplies 400+ products to nutraceutical, food, pharmaceutical, and biomedical manufacturers via direct B2B enterprise sales.

Ownership category

akta.pro rank

Headquarters

HQ city

Mukwonago

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Collagen Peptides: Sale of collagen peptide ingredients to nutraceutical, functional food, and supplement manufacturers for health and wellness applications
2. Gelatin Ingredients: Sale of functional gelatins for food, pharmaceutical, and nutraceutical applications including capsules and coatings
3. Biomaterials: Specialized gelatin and modified gelatin products for biomedical research, medical devices, and in-body applications

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Core offering

Rousselot manufactures and sells collagen peptides, functional gelatins, and specialized biomaterials derived from animal agriculture and food industry byproducts for B2B customers. Its portfolio serves health and nutrition, food and beverage, pharmaceutical, and biomedical sectors through more than 400 products across three core lines: Peptan collagen peptides, gelatin ingredients, and biomaterials including X-Pure and Nextida GC.

Product overview

Rousselot is a world-leading collagen and gelatin ingredient manufacturer operating 16 production facilities across 4 continents with 30% global market share. The company offers over 400 gelatin and collagen products organized into three core product lines: Peptan (collagen peptides for holistic and targeted health benefits including blood glucose support with Nextida GC and joint health with Colartix), Gelatin (functional gelatins for food, pharmaceutical, and nutraceutical applications), and Biomaterials (including X-Pure for regenerative medicine and biomedical research). Rousselot serves the health and nutrition, food, biomedical, and pharmaceutical sectors with science-backed ingredient solutions.

Differentiator

Problem solved

Functional benefit

Brands

• Peptan: Collagen peptides for health and nutrition supplements and functional foods
• Colartix
• X-Pure
• Nextida GC
• Nextida

Products and services

• Peptan Collagen Peptides Collagen peptide solutions with holistic and targeted health benefits for dietary supplements, functional foods, and beverages. The range is Upcycled Certified for sustainable sourcing.
• Rousselot Gelatin Functional gelatins for food, pharmaceutical, and nutraceutical applications including capsules, coatings, and medical devices.
• Rousselot Biomaterials Gelatins and modified gelatins for biomedical applications including regenerative medicine and 3D bioprinting research.
• Nextida GC First-of-its-kind collagen peptide ingredient supporting healthy after-meal blood glucose regulation. Protected by U.S. Patent US12636339 plus patents granted in Australia, Europe, Japan, and China.
• Colartix Unique hydrolyzed cartilage matrix with science supporting joint discomfort relief. Protected by patents granted in Europe, Japan, and China.
• X-Pure Biomaterial product line within the biomedical portfolio for research and in-body medical applications.

Quantifiable outcome

• 30% global market share in collagen and gelatin
• +2 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• GLP-1 Medication Users / Food ManufacturersminorOthersRousselot is positioned among companies including PepsiCo, ADM, Corbion, Bay State Milling, CII Foods, Ardent Mills, and Cargill offering protein ingredients and finished products tailored to GLP-1 medication users who seek nutrient-dense options. Rousselot provides collagen peptide ingredients for this emerging consumer segment.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Cargill: Cargill is a global food and ingredient incumbent with broad protein, texturizer, and functional food capabilities, including hydrolyzed proteins. It is a broad incumbent comparable to Rousselot in customer base and food/B2B scale, and is named alongside Rousselot as a major supplier to the GLP-1 companion nutrition opportunity.
• ADM (Archer Daniels Midland): ADM is a global food and nutrition ingredient incumbent offering a broad portfolio of proteins, flavors, and functional ingredients including plant-based proteins. ADM overlaps with Rousselot in the functional food and nutrition space, and is explicitly named alongside Rousselot as a supplier to the GLP-1 companion nutrition segment.
• Kerry Group: Kerry Group is a global taste and nutrition ingredients incumbent with a broad portfolio serving food, beverage, and supplement manufacturers. It competes with Rousselot in functional food and beverage ingredients, particularly in protein fortification and clean-label texturizer solutions.

Emerging players

• Amicogen: Amicogen is a South Korea-based producer specializing in collagen peptides, gelatin, and bioactive peptides for nutraceutical and food applications. It is an emerging player with growing international presence that competes with Rousselot in the collagen peptide segment, particularly in Asia-Pacific markets.
• Jellagen Pty Ltd: Jellagen is a UK-based emerging player specializing in marine collagen (jellyfish-derived) for biomedical, cell culture, and regenerative medicine applications. It overlaps with Rousselot's biomedical/biomaterials segment and represents a potential substitute-source competitor in research-grade collagen.

Direct peers

• Gelita AG: Gelita AG is Rousselot's closest direct competitor, a Germany-based global manufacturer of gelatin and collagen peptides for food, health, pharma, and biomedical applications. Together the two companies account for the majority of the global hydrolyzed collagen market, competing head-to-head on Peptan-equivalent peptide ranges and pharmaceutical-grade gelatins.
• Weishardt Group: Weishardt is a French privately-held producer of gelatin and collagen peptides for food, nutrition, and pharmaceutical applications. It is a direct peer with European manufacturing footprint and comparable product portfolio to Rousselot, though with smaller global scale.
• Nitta Gelatin: Nitta Gelatin is a Japan-based producer of gelatin and collagen peptides serving food, health, and pharmaceutical markets across Asia and globally. It is a relevant direct peer, particularly in Asian markets and in pharmaceutical-grade gelatin where it competes with Rousselot's X-Pure biomaterials.
• Tessenderlo Group (PB Leiner): PB Leiner, part of Tessenderlo Group, is a global gelatin and collagen peptides producer with operations in Europe, North America, South America, and Asia. It directly competes with Rousselot across food, nutraceutical, and pharmaceutical-grade gelatin applications, and is one of the few players with comparable multinational production scale.

Others

• Darling Ingredients Inc. (Parent): Darling Ingredients Inc. (NYSE: DAR) is Rousselot's publicly listed parent company, with $1.55B Q1 2026 revenue across Feed, Food, and Fuel segments. While not a peer in the traditional sense, DAR provides context for Rousselot's valuation, as Rousselot is the Food segment's flagship health brand.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/RousselotGlobal
• YouTubeyoutube.com/channel/UCk2iEQl4vCzW7krc6kV2NCA
• Facebookfacebook.com/Rousselot-117959708301792
• LinkedInlinkedin.com/company/rousselot
• Instagraminstagram.com/rousselotglobal

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rousselot